Free Trial

SiBone (SIBN) Financials

SiBone logo
$16.73 -0.37 (-2.16%)
Closing price 07/17/2025 04:00 PM Eastern
Extended Trading
$16.74 +0.00 (+0.03%)
As of 07/17/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for SiBone

Annual Income Statements for SiBone

This table shows SiBone's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders
-23 -17 -38 -44 -57 -61 -43 -31
Consolidated Net Income / (Loss)
-23 -17 -38 -44 -57 -61 -43 -31
Net Income / (Loss) Continuing Operations
-23 -17 -38 -44 -57 -61 -43 -31
Total Pre-Tax Income
-23 -17 -38 -44 -57 -61 -43 -31
Total Operating Income
-17 -12 -36 -39 -52 -60 -47 -35
Total Gross Profit
43 51 61 64 80 91 109 132
Total Revenue
48 55 67 73 90 106 139 167
Operating Revenue
48 55 67 73 90 106 139 167
Total Cost of Revenue
5.11 4.83 6.79 8.90 10 16 29 35
Operating Cost of Revenue
5.11 4.83 6.79 8.90 10 16 29 35
Total Operating Expenses
60 63 97 103 131 150 156 167
Selling, General & Admin Expense
13 13 21 20 25 29 31 34
Marketing Expense
42 44 68 74 94 108 110 117
Research & Development Expense
5.51 5.38 7.28 9.46 12 14 15 17
Total Other Income / (Expense), net
-5.69 -5.49 -2.40 -5.13 -4.90 -1.52 3.45 4.41
Interest Expense
6.20 5.11 4.95 6.10 5.37 2.82 3.46 3.44
Interest & Investment Income
0.18 0.77 2.55 1.10 0.19 1.30 6.92 7.85
Other Gains / (Losses), net
- - - - - -0.13 0.14 -0.07
Basic Earnings per Share
($6.65) ($2.20) ($1.55) ($1.50) ($1.71) ($1.79) ($1.13) ($0.75)
Weighted Average Basic Shares Outstanding
3.47M 7.95M 24.71M 29.06M 33.15M 34.20M 38.43M 41.47M
Diluted Earnings per Share
($6.65) ($2.20) ($1.55) ($1.50) ($1.71) ($1.79) ($1.13) ($0.75)
Weighted Average Diluted Shares Outstanding
3.47M 7.95M 24.71M 29.06M 33.15M 34.20M 38.43M 41.47M
Weighted Average Basic & Diluted Shares Outstanding
3.47M 7.95M 24.71M 29.06M 33.84M 34.99M 41.06M 42.45M
Cash Dividends to Common per Share
$0.00 $0.00 $0.00 $0.00 $0.00 - $0.00 $0.00

Quarterly Income Statements for SiBone

This table shows SiBone's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-14 -11 -11 -11 -10 -11 -11 -8.94 -6.58 -4.50 -6.54
Consolidated Net Income / (Loss)
-14 -11 -11 -11 -10 -11 -11 -8.94 -6.58 -4.50 -6.54
Net Income / (Loss) Continuing Operations
-14 -11 -11 -11 -10 -11 -11 -8.94 -6.58 -4.50 -6.54
Total Pre-Tax Income
-14 -11 -11 -11 -10 -11 -11 -8.94 -6.58 -4.42 -6.54
Total Operating Income
-14 -11 -11 -12 -11 -13 -12 -10 -7.63 -5.49 -7.48
Total Gross Profit
22 27 27 27 27 29 30 32 32 39 38
Total Revenue
26 32 33 33 34 39 38 40 40 49 47
Operating Revenue
26 32 33 33 34 39 38 40 40 49 47
Total Cost of Revenue
4.17 5.09 5.92 6.32 7.04 10 8.00 8.39 8.44 10 9.60
Operating Cost of Revenue
4.17 5.09 5.92 6.32 7.04 10 8.00 8.39 8.44 10 9.60
Total Operating Expenses
36 38 38 39 38 41 42 42 40 44 45
Selling, General & Admin Expense
7.07 7.07 7.47 7.80 7.71 8.08 8.18 8.33 8.10 9.15 9.96
Marketing Expense
26 28 27 27 27 29 29 29 27 31 31
Research & Development Expense
3.09 3.48 3.29 3.66 3.92 4.16 4.35 4.35 3.99 3.87 4.53
Total Other Income / (Expense), net
-0.59 0.25 0.17 0.76 1.15 1.38 1.14 1.14 1.05 1.08 0.94
Interest Expense
0.76 0.88 0.84 0.85 0.88 0.89 0.88 0.88 0.88 0.80 0.66
Interest & Investment Income
0.35 0.75 0.93 1.58 2.17 2.23 2.11 2.02 1.94 1.78 1.59
Other Income / (Expense), net
-0.18 - 0.07 0.03 -0.14 - -0.09 0.00 - - 0.01
Basic Earnings per Share
($0.41) ($0.32) ($0.32) ($0.30) ($0.25) ($0.26) ($0.27) ($0.22) ($0.16) ($0.10) ($0.15)
Weighted Average Basic Shares Outstanding
34.36M 34.20M 34.92M 37.86M 40.27M 38.43M 40.93M 41.32M 41.72M 41.47M 42.34M
Diluted Earnings per Share
($0.41) ($0.32) ($0.32) ($0.30) ($0.25) ($0.26) ($0.27) ($0.22) ($0.16) ($0.10) ($0.15)
Weighted Average Diluted Shares Outstanding
34.36M 34.20M 34.92M 37.86M 40.27M 38.43M 40.93M 41.32M 41.72M 41.47M 42.34M
Weighted Average Basic & Diluted Shares Outstanding
34.50M 34.99M 35.18M 40.20M 40.50M 41.06M 41.20M 41.69M 41.94M 42.45M 42.61M

Annual Cash Flow Statements for SiBone

This table details how cash moves in and out of SiBone's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents
-5.49 2.71 -15 43 9.84 -43 13 1.68
Net Cash From Operating Activities
-18 -15 -32 -31 -40 -42 -19 -12
Net Cash From Continuing Operating Activities
-18 -15 -32 -31 -40 -42 -19 -12
Net Income / (Loss) Continuing Operations
-23 -17 -38 -44 -57 -61 -43 -31
Consolidated Net Income / (Loss)
-23 -17 -38 -44 -57 -61 -43 -31
Depreciation Expense
1.01 0.72 0.77 1.13 2.09 3.45 5.43 4.38
Amortization Expense
0.29 0.05 -1.15 0.41 1.58 0.43 -3.80 -5.29
Non-Cash Adjustments To Reconcile Net Income
3.83 3.19 7.64 14 19 24 28 30
Changes in Operating Assets and Liabilities, net
0.38 -1.03 -0.48 -2.53 -5.76 -7.96 -4.83 -10
Net Cash From Investing Activities
-0.48 -98 13 -63 52 -2.82 -60 13
Net Cash From Continuing Investing Activities
-0.48 -98 13 -63 52 -2.82 -60 13
Purchase of Property, Plant & Equipment
-0.48 -0.94 -2.45 -2.56 -6.39 -9.51 -7.80 -10
Purchase of Investments
0.00 -97 -144 -179 -102 -120 -189 -205
Sale and/or Maturity of Investments
- 0.00 160 119 160 126 138 229
Net Cash From Financing Activities
13 115 3.49 136 -1.71 2.20 91 1.96
Net Cash From Continuing Financing Activities
13 115 3.49 136 -1.71 2.20 91 1.96
Repayment of Debt
-32 - 0.00 -47 -42 0.00 -35 -36
Issuance of Debt
40 - 0.00 45 35 0.00 36 36
Issuance of Common Equity
0.00 116 2.20 137 2.34 1.82 86 2.15
Other Financing Activities, net
0.38 1.61 1.49 1.46 2.57 0.38 4.39 -0.15
Effect of Exchange Rate Changes
-0.35 - - 0.32 -0.50 -0.43 0.13 -0.48
Cash Interest Paid
4.51 5.50 4.95 4.28 3.23 2.62 3.26 3.35

Quarterly Cash Flow Statements for SiBone

This table details how cash moves in and out of SiBone's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Change in Cash & Equivalents
1.98 -5.58 2.25 88 -57 -20 -1.23 -6.46 4.65 4.72 6.24
Net Cash From Operating Activities
-6.53 -6.78 -11 -3.59 -2.07 -2.30 -7.57 -6.33 0.30 1.18 -4.91
Net Cash From Continuing Operating Activities
-6.53 -6.78 -11 -3.59 -2.07 -2.30 -7.57 -6.33 0.30 1.18 -4.91
Net Income / (Loss) Continuing Operations
-14 -11 -11 -11 -10 -11 -11 -8.94 -6.58 -4.50 -6.54
Consolidated Net Income / (Loss)
-14 -11 -11 -11 -10 -11 -11 -8.94 -6.58 -4.50 -6.54
Depreciation Expense
0.95 1.00 1.09 1.24 1.53 1.57 1.09 0.99 1.09 1.21 1.28
Amortization Expense
0.16 -0.35 -0.53 -0.59 -1.13 -1.55 -1.52 -1.42 -1.19 -1.16 -0.89
Non-Cash Adjustments To Reconcile Net Income
6.00 6.32 6.43 6.36 6.81 8.23 7.50 7.35 7.08 7.59 7.44
Changes in Operating Assets and Liabilities, net
0.53 -2.57 -6.61 0.61 0.73 0.44 -3.74 -4.33 -0.09 -1.97 -6.20
Net Cash From Investing Activities
8.73 0.09 12 2.28 -55 -19 6.35 -1.83 3.77 4.34 11
Net Cash From Continuing Investing Activities
8.73 0.09 12 2.28 -55 -19 6.35 -1.83 3.77 4.34 11
Purchase of Property, Plant & Equipment
-3.57 -1.66 -2.58 -2.71 -1.41 -1.09 -2.08 -3.11 -3.04 -2.27 -2.07
Purchase of Investments
-30 -34 -16 -34 -78 -62 -59 -51 -61 -35 -47
Sale and/or Maturity of Investments
42 36 30 39 25 44 67 52 68 42 60
Net Cash From Financing Activities
0.11 0.69 1.21 89 -0.24 0.84 0.11 1.78 0.16 -0.08 0.10
Net Cash From Continuing Financing Activities
0.11 0.69 1.21 89 -0.24 0.84 0.11 1.78 0.16 -0.08 0.10
Other Financing Activities, net
0.11 0.07 0.52 3.52 0.23 0.12 0.11 0.30 0.16 -0.71 0.10
Effect of Exchange Rate Changes
-0.33 0.41 0.10 0.03 -0.14 0.15 -0.11 -0.08 0.42 -0.71 0.42

Annual Balance Sheets for SiBone

This table presents SiBone's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets
36 139 117 223 191 158 230 230
Total Current Assets
34 136 111 218 176 138 211 208
Cash & Equivalents
22 25 10 54 63 21 33 35
Short-Term Investments
0.00 97 81 143 84 77 133 115
Accounts Receivable
7.42 8.49 12 14 14 21 22 27
Inventories, net
2.55 3.34 5.45 5.63 11 17 20 27
Prepaid Expenses
1.25 1.99 2.51 2.57 3.14 2.37 3.17 3.20
Plant, Property, & Equipment, net
1.90 2.15 3.95 4.53 8.99 16 16 20
Total Noncurrent Assets
0.31 0.33 1.59 0.37 5.65 4.38 3.03 2.28
Other Noncurrent Operating Assets
0.31 0.33 0.32 0.37 5.65 4.38 3.03 2.28
Total Liabilities & Shareholders' Equity
36 139 117 223 191 158 230 230
Total Liabilities
47 48 54 54 56 59 61 63
Total Current Liabilities
7.54 9.01 19 13 17 21 23 27
Accounts Payable
1.81 2.15 2.81 3.27 3.20 6.28 4.59 6.49
Accrued Expenses
5.72 6.86 12 10 12 14 17 19
Other Current Liabilities
- - - - 1.34 1.39 1.42 1.15
Total Noncurrent Liabilities
39 39 35 40 39 38 38 36
Long-Term Debt
39 39 35 39 35 35 36 35
Capital Lease Obligations
- - - - 4.17 2.87 1.51 0.88
Other Noncurrent Operating Liabilities
0.42 0.36 0.36 0.85 0.06 0.03 0.02 0.01
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-129 90 63 169 134 98 169 167
Total Preferred & Common Equity
-129 90 63 169 134 98 169 167
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
-129 90 63 169 134 98 169 167
Common Stock
9.94 247 258 408 430 455 569 598
Retained Earnings
-140 -157 -196 -239 -296 -357 -400 -431
Accumulated Other Comprehensive Income / (Loss)
0.40 0.44 0.46 0.52 0.35 0.23 0.34 0.24

Quarterly Balance Sheets for SiBone

This table presents SiBone's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2022 Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025
Period end date 6/30/2022 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025
Total Assets
166 158 149 234 231 224 224 227 227
Total Current Assets
148 139 128 213 211 204 202 204 204
Cash & Equivalents
24 26 23 111 53 32 26 30 41
Short-Term Investments
90 78 63 59 113 126 126 121 103
Accounts Receivable
15 16 23 20 20 22 25 25 27
Inventories, net
16 17 18 21 22 21 23 26 30
Prepaid Expenses
2.33 1.79 2.05 2.14 1.94 2.65 2.78 2.45 2.70
Plant, Property, & Equipment, net
13 14 17 18 16 17 19 21 21
Total Noncurrent Assets
5.00 4.64 4.05 3.71 3.37 2.74 2.40 2.55 2.00
Other Noncurrent Operating Assets
5.00 4.64 4.05 3.71 3.37 2.74 2.40 2.55 2.00
Total Liabilities & Shareholders' Equity
166 158 149 234 231 224 224 227 227
Total Liabilities
55 55 55 56 57 58 59 62 60
Total Current Liabilities
17 19 17 18 19 21 22 25 24
Accounts Payable
5.14 4.61 5.33 6.16 4.42 7.66 7.18 7.32 7.71
Accrued Expenses
10 11 9.90 11 14 12 13 16 15
Other Current Liabilities
1.34 1.34 1.40 1.40 1.40 1.43 1.38 1.21 1.09
Total Noncurrent Liabilities
39 37 38 38 38 37 37 37 36
Long-Term Debt
35 34 36 36 36 36 36 36 35
Capital Lease Obligations
3.53 3.18 2.53 2.21 1.87 1.19 0.89 1.14 0.58
Other Noncurrent Operating Liabilities
0.04 0.03 0.03 0.02 0.02 0.02 0.01 0.01 0.00
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
111 103 94 177 174 166 165 165 167
Total Preferred & Common Equity
111 103 94 177 174 166 165 165 167
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
111 103 94 177 174 166 165 165 167
Common Stock
443 449 462 557 563 577 585 591 605
Retained Earnings
-332 -346 -368 -379 -389 -411 -420 -427 -438
Accumulated Other Comprehensive Income / (Loss)
0.03 0.16 0.30 0.30 0.36 0.27 0.23 0.58 0.32

Annual Metrics And Ratios for SiBone

This table displays calculated financial ratios and metrics derived from SiBone's official financial filings.

Metric 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics
- - - - - - - -
Revenue Growth
0.00% 15.42% 21.53% 9.04% 22.84% 18.03% 30.52% 20.37%
EBITDA Growth
0.00% 21.45% -194.81% -2.12% -28.44% -16.77% 18.71% 20.19%
EBIT Growth
0.00% 22.90% -174.55% -7.47% -32.82% -15.99% 21.27% 24.89%
NOPAT Growth
0.00% 31.04% -200.90% -7.12% -33.97% -15.36% 21.27% 24.89%
Net Income Growth
0.00% 24.25% -120.04% -13.79% -29.46% -8.28% 29.25% 28.67%
EPS Growth
0.00% 66.92% 29.55% 3.23% -14.00% -4.68% 36.87% 33.63%
Operating Cash Flow Growth
0.00% 17.18% -117.83% 3.05% -28.93% -5.37% 55.08% 33.60%
Free Cash Flow Firm Growth
0.00% 0.00% -178.85% -10.08% -66.71% -7.62% 35.92% -6.52%
Invested Capital Growth
0.00% 26.82% 32.33% 35.03% 114.60% 46.93% 4.81% 30.10%
Revenue Q/Q Growth
0.00% 0.00% 6.63% 3.28% 3.54% 6.74% 5.23% 6.46%
EBITDA Q/Q Growth
0.00% 0.00% -11.16% 2.11% -13.27% 4.69% -4.73% 16.30%
EBIT Q/Q Growth
0.00% 0.00% -11.64% 0.98% -13.15% 4.84% -3.12% 16.59%
NOPAT Q/Q Growth
0.00% 0.00% -13.13% 1.57% -13.29% 4.24% -2.65% 16.59%
Net Income Q/Q Growth
0.00% 0.00% -10.93% 0.27% -10.76% 5.11% 0.44% 17.35%
EPS Q/Q Growth
0.00% 0.00% -2,483.33% 6.25% -11.76% 6.28% 5.04% 17.58%
Operating Cash Flow Q/Q Growth
0.00% -18.64% -9.39% 3.62% -13.92% 12.48% 19.31% 21.86%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% -0.09% -25.17% 13.87% 12.50% -1.83%
Invested Capital Q/Q Growth
0.00% 0.00% 38.50% 32.06% 50.26% 5.43% -8.50% 3.44%
Profitability Metrics
- - - - - - - -
Gross Margin
89.35% 91.27% 89.91% 87.87% 88.43% 85.24% 78.78% 79.03%
EBITDA Margin
-32.74% -22.29% -54.06% -50.63% -52.94% -52.37% -32.62% -21.63%
Operating Margin
-36.16% -21.61% -53.50% -52.55% -57.31% -56.02% -33.79% -21.08%
EBIT Margin
-35.45% -23.68% -53.50% -52.72% -57.01% -56.02% -33.79% -21.08%
Profit (Net Income) Margin
-48.01% -31.52% -57.06% -59.54% -62.75% -57.57% -31.20% -18.49%
Tax Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.22% 99.68% 100.24%
Interest Burden Percent
135.44% 133.09% 106.66% 112.93% 110.08% 102.54% 92.64% 87.49%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-222.19% -135.11% -312.97% -250.45% -185.64% -127.15% -82.14% -52.39%
ROIC Less NNEP Spread (ROIC-NNEP)
-289.04% -108.00% -293.71% -234.60% -170.23% -103.77% -70.97% -47.24%
Return on Net Nonoperating Assets (RNNOA)
434.92% 91.13% 262.84% 212.84% 148.40% 74.51% 49.76% 34.01%
Return on Equity (ROE)
212.73% -43.98% -50.13% -37.61% -37.25% -52.64% -32.38% -18.38%
Cash Return on Invested Capital (CROIC)
0.00% -158.76% -340.80% -280.25% -258.50% -165.16% -86.84% -78.56%
Operating Return on Assets (OROA)
-47.47% -15.04% -28.18% -22.75% -24.85% -34.25% -24.19% -15.30%
Return on Assets (ROA)
-64.29% -20.02% -30.06% -25.69% -27.35% -35.20% -22.34% -13.42%
Return on Common Equity (ROCE)
2,541.37% 21.72% -50.13% -37.61% -37.25% -52.64% -32.38% -18.38%
Return on Equity Simple (ROE_SIMPLE)
17.81% -19.35% -60.95% -25.80% -42.09% -62.31% -25.59% -18.51%
Net Operating Profit after Tax (NOPAT)
-12 -8.38 -25 -27 -36 -42 -33 -25
NOPAT Margin
-25.31% -15.12% -37.45% -36.79% -40.12% -39.21% -23.65% -14.76%
Net Nonoperating Expense Percent (NNEP)
66.85% -27.11% -19.26% -15.84% -15.41% -23.38% -11.17% -5.15%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - -30.60% -15.87% -12.14%
Cost of Revenue to Revenue
10.65% 8.73% 10.09% 12.13% 11.57% 14.76% 21.22% 20.97%
SG&A Expenses to Revenue
27.22% 22.82% 31.18% 26.98% 27.81% 27.22% 22.37% 20.19%
R&D to Revenue
11.49% 9.71% 10.82% 12.89% 13.80% 12.81% 10.82% 9.91%
Operating Expenses to Revenue
125.50% 112.88% 143.41% 140.42% 145.75% 141.26% 112.58% 100.11%
Earnings before Interest and Taxes (EBIT)
-17 -13 -36 -39 -51 -60 -47 -35
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-16 -12 -36 -37 -48 -56 -45 -36
Valuation Ratios
- - - - - - - -
Price to Book Value (P/BV)
0.00 5.64 8.53 5.71 5.53 4.77 5.02 3.52
Price to Tangible Book Value (P/TBV)
0.00 5.64 8.53 5.71 5.53 4.77 5.02 3.52
Price to Revenue (P/Rev)
2.25 9.18 7.99 13.18 8.25 4.41 6.12 3.52
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
44.43 61.33 52.74 65.45 23.93 10.50 17.63 8.91
Enterprise Value to Revenue (EV/Rev)
5.06 7.68 7.19 11.05 7.05 3.85 5.20 2.84
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - -
Debt to Equity
-3.57 0.43 0.62 0.23 0.29 0.39 0.22 0.22
Long-Term Debt to Equity
-3.57 0.43 0.55 0.23 0.29 0.39 0.22 0.22
Financial Leverage
-1.50 -0.84 -0.89 -0.91 -0.87 -0.72 -0.70 -0.72
Leverage Ratio
-3.31 2.20 1.67 1.46 1.36 1.50 1.45 1.37
Compound Leverage Factor
-4.48 2.92 1.78 1.65 1.50 1.53 1.34 1.20
Debt to Total Capital
138.85% 30.17% 38.37% 18.89% 22.55% 27.90% 18.16% 17.87%
Short-Term Debt to Total Capital
0.00% 0.00% 4.26% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
138.85% 30.17% 34.10% 18.89% 22.55% 27.90% 18.16% 17.87%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
425.30% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
-464.15% 69.83% 61.63% 81.11% 77.45% 72.10% 81.84% 82.13%
Debt to EBITDA
-2.46 -3.16 -1.08 -1.06 -0.82 -0.68 -0.83 -1.00
Net Debt to EBITDA
-1.04 6.75 1.48 4.22 2.26 1.06 2.84 3.15
Long-Term Debt to EBITDA
-2.46 -3.16 -0.96 -1.06 -0.82 -0.68 -0.83 -1.00
Debt to NOPAT
-3.19 -4.65 -1.56 -1.46 -1.08 -0.91 -1.14 -1.47
Net Debt to NOPAT
-1.34 9.94 2.14 5.81 2.98 1.42 3.91 4.61
Long-Term Debt to NOPAT
-3.19 -4.65 -1.38 -1.46 -1.08 -0.91 -1.14 -1.47
Altman Z-Score
-3.42 5.91 4.14 10.15 6.37 1.89 6.83 4.10
Noncontrolling Interest Sharing Ratio
-1,094.63% 149.38% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - -
Current Ratio
4.46 15.11 5.94 16.20 10.41 6.50 9.01 7.66
Quick Ratio
3.96 14.51 5.51 15.59 9.55 5.57 8.01 6.54
Cash Flow Metrics
- - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -9.84 -27 -30 -50 -54 -35 -37
Operating Cash Flow to CapEx
-3,667.36% -1,541.30% -1,293.54% -1,197.27% -618.77% -438.15% -239.94% -118.37%
Free Cash Flow to Firm to Interest Expense
0.00 -1.93 -5.55 -4.95 -9.39 -19.23 -10.03 -10.75
Operating Cash Flow to Interest Expense
-2.83 -2.84 -6.39 -5.03 -7.37 -14.78 -5.41 -3.61
Operating Cash Flow Less CapEx to Interest Expense
-2.90 -3.03 -6.88 -5.45 -8.56 -18.15 -7.66 -6.66
Efficiency Ratios
- - - - - - - -
Asset Turnover
1.34 0.64 0.53 0.43 0.44 0.61 0.72 0.73
Accounts Receivable Turnover
6.47 6.97 6.66 5.79 6.47 6.09 6.52 6.77
Inventory Turnover
2.00 1.64 1.54 1.61 1.22 1.09 1.57 1.48
Fixed Asset Turnover
25.31 27.35 22.04 17.31 13.34 8.67 8.80 9.19
Accounts Payable Turnover
2.82 2.44 2.74 2.93 3.22 3.31 5.42 6.33
Days Sales Outstanding (DSO)
56.41 52.40 54.79 62.99 56.39 59.89 56.01 53.94
Days Inventory Outstanding (DIO)
182.29 222.64 236.39 227.25 299.81 334.44 232.45 246.35
Days Payable Outstanding (DPO)
129.52 149.53 133.23 124.69 113.21 110.13 67.31 57.66
Cash Conversion Cycle (CCC)
109.18 125.51 157.95 165.56 242.99 284.20 221.16 242.64
Capital & Investment Metrics
- - - - - - - -
Invested Capital
5.47 6.93 9.17 12 27 39 41 53
Invested Capital Turnover
8.78 8.93 8.36 6.81 4.63 3.24 3.47 3.55
Increase / (Decrease) in Invested Capital
0.00 1.47 2.24 3.21 14 12 1.88 12
Enterprise Value (EV)
243 425 484 811 636 410 722 474
Market Capitalization
108 508 538 968 744 469 850 588
Book Value per Share
($37.32) $3.71 $2.52 $5.23 $4.01 $2.85 $4.18 $3.98
Tangible Book Value per Share
($37.32) $3.71 $2.52 $5.23 $4.01 $2.85 $4.18 $3.98
Total Capital
28 129 102 209 174 136 207 203
Total Debt
39 39 39 39 39 38 38 36
Total Long-Term Debt
39 39 35 39 39 38 38 36
Net Debt
16 -83 -54 -157 -108 -59 -128 -114
Capital Expenditures (CapEx)
0.48 0.94 2.45 2.56 6.39 9.51 7.80 10
Debt-free, Cash-free Net Working Capital (DFCFNWC)
3.68 4.81 5.27 8.34 12 19 22 31
Debt-free Net Working Capital (DFNWC)
26 127 97 205 159 116 188 181
Net Working Capital (NWC)
26 127 93 205 159 116 188 181
Net Nonoperating Expense (NNE)
11 9.08 13 17 20 20 10 6.24
Net Nonoperating Obligations (NNO)
16 -83 -54 -157 -108 -59 -128 -114
Total Depreciation and Amortization (D&A)
1.30 0.77 -0.38 1.54 3.67 3.88 1.63 -0.91
Debt-free, Cash-free Net Working Capital to Revenue
7.68% 8.69% 7.82% 11.36% 13.31% 17.99% 15.78% 18.31%
Debt-free Net Working Capital to Revenue
54.38% 229.39% 144.20% 279.03% 176.34% 109.42% 135.32% 108.06%
Net Working Capital to Revenue
54.38% 229.39% 137.72% 279.03% 176.34% 109.42% 135.32% 108.06%
Earnings Adjustments
- - - - - - - -
Adjusted Basic Earnings per Share
($6.65) ($2.20) ($1.55) ($1.50) ($1.71) ($1.79) ($1.13) ($0.75)
Adjusted Weighted Average Basic Shares Outstanding
3.47M 24.46M 28.38M 32.73M 33.15M 34.20M 38.43M 41.47M
Adjusted Diluted Earnings per Share
($6.65) ($2.20) ($1.55) ($1.50) ($1.71) ($1.79) ($1.13) ($0.75)
Adjusted Weighted Average Diluted Shares Outstanding
3.47M 24.46M 28.38M 32.73M 33.15M 34.20M 38.43M 41.47M
Adjusted Basic & Diluted Earnings per Share
($6.65) ($2.20) ($1.55) ($1.50) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
3.47M 7.95M 24.71M 29.06M 33.84M 34.99M 41.06M 42.45M
Normalized Net Operating Profit after Tax (NOPAT)
-12 -8.38 -25 -27 -36 -42 -33 -25
Normalized NOPAT Margin
-25.31% -15.12% -37.45% -36.79% -40.12% -39.21% -23.65% -14.76%
Pre Tax Income Margin
-48.01% -31.52% -57.06% -59.54% -62.75% -57.44% -31.30% -18.45%
Debt Service Ratios
- - - - - - - -
EBIT to Interest Expense
-2.74 -2.57 -7.28 -6.34 -9.58 -21.15 -13.56 -10.25
NOPAT to Interest Expense
-1.96 -1.64 -5.09 -4.43 -6.74 -14.80 -9.49 -7.17
EBIT Less CapEx to Interest Expense
-2.82 -2.75 -7.77 -6.76 -10.77 -24.52 -15.81 -13.30
NOPAT Less CapEx to Interest Expense
-2.03 -1.82 -5.59 -4.84 -7.93 -18.17 -11.74 -10.22
Payout Ratios
- - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-5.61% -11.29% -0.43% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for SiBone

This table displays calculated financial ratios and metrics derived from SiBone's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
18.60% 26.65% 45.76% 30.17% 28.68% 21.61% 15.77% 20.01% 18.60% 26.10% 24.88%
EBITDA Growth
-3.01% 18.15% 32.97% 33.23% 13.75% -17.29% -17.80% 7.06% 29.01% 56.41% 43.65%
EBIT Growth
-3.70% 19.00% 33.70% 33.78% 17.72% -10.73% -8.17% 15.61% 32.52% 56.07% 38.43%
NOPAT Growth
-2.78% 18.93% 33.05% 33.10% 17.67% -10.73% -6.64% 15.76% 31.66% 56.07% 37.89%
Net Income Growth
10.80% 22.81% 36.10% 39.47% 29.21% 1.72% 1.99% 20.23% 34.39% 59.07% 40.00%
EPS Growth
14.58% 27.27% 38.46% 44.44% 39.02% 18.75% 15.63% 26.67% 36.00% 61.54% 44.44%
Operating Cash Flow Growth
29.89% 46.71% 20.42% 75.81% 68.24% 66.10% 29.59% -76.43% 114.57% 151.28% 35.13%
Free Cash Flow Firm Growth
-64.40% 14.89% 9.62% 35.67% 46.25% 47.83% 70.57% 42.99% 22.03% -52.06% -173.84%
Invested Capital Growth
109.42% 46.93% 51.72% 31.82% 20.76% 4.81% -3.10% 8.82% 15.09% 30.10% 30.88%
Revenue Q/Q Growth
3.31% 20.89% 2.36% 1.83% 2.13% 14.24% -2.55% 5.55% 0.93% 21.47% -3.49%
EBITDA Q/Q Growth
25.25% 15.83% -2.66% -5.88% 3.44% -14.46% -2.19% 16.47% 26.26% 29.71% -30.14%
EBIT Q/Q Growth
23.73% 17.86% -1.59% -6.41% 5.24% -10.56% 1.50% 16.99% 24.23% 28.02% -36.00%
NOPAT Q/Q Growth
24.13% 16.75% 0.01% -5.93% 6.64% -11.97% 3.70% 16.32% 24.26% 28.02% -36.15%
Net Income Q/Q Growth
23.52% 21.07% 0.45% -0.73% 10.57% -9.59% 0.72% 18.02% 26.45% 31.64% -45.54%
EPS Q/Q Growth
24.07% 21.95% 0.00% 6.25% 16.67% -4.00% -3.85% 18.52% 27.27% 37.50% -50.00%
Operating Cash Flow Q/Q Growth
56.02% -3.80% -58.72% 66.61% 42.26% -10.81% -229.60% 16.34% 104.77% 290.07% -516.89%
Free Cash Flow Firm Q/Q Growth
4.92% 29.36% -16.49% 17.78% 20.55% 31.44% 34.27% -59.24% -8.67% -33.70% -18.37%
Invested Capital Q/Q Growth
5.77% 5.43% 18.95% -0.62% -3.11% -8.50% 9.97% 11.61% 2.47% 3.44% 10.63%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
84.23% 84.07% 81.89% 81.03% 79.30% 73.80% 78.87% 79.00% 79.09% 79.13% 79.71%
EBITDA Margin
-47.83% -33.31% -32.61% -33.91% -32.06% -32.12% -33.18% -26.26% -19.19% -11.10% -14.97%
Operating Margin
-51.32% -35.35% -34.53% -35.92% -32.84% -32.18% -31.80% -25.21% -18.92% -11.21% -15.82%
EBIT Margin
-52.02% -35.35% -34.30% -35.84% -33.26% -32.18% -32.05% -25.20% -18.92% -11.21% -15.80%
Profit (Net Income) Margin
-53.56% -34.97% -34.01% -33.65% -29.46% -28.26% -28.80% -22.36% -16.30% -9.17% -13.83%
Tax Burden Percent
100.00% 101.20% 100.00% 100.00% 100.00% 98.73% 100.00% 100.00% 99.91% 101.79% 100.00%
Interest Burden Percent
102.97% 97.78% 99.16% 93.87% 88.60% 88.95% 89.85% 88.73% 86.22% 80.38% 87.55%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-130.87% -80.23% -73.17% -77.05% -74.19% -78.23% -70.12% -55.18% -43.23% -27.86% -37.63%
ROIC Less NNEP Spread (ROIC-NNEP)
-126.01% -76.31% -68.55% -74.31% -71.93% -75.86% -67.17% -53.65% -42.22% -27.33% -36.49%
Return on Net Nonoperating Assets (RNNOA)
98.02% 54.79% 44.13% 53.38% 50.65% 53.19% 43.49% 38.53% 30.22% 19.67% 25.09%
Return on Equity (ROE)
-32.85% -25.44% -29.04% -23.67% -23.54% -25.04% -26.62% -16.65% -13.01% -8.19% -12.54%
Cash Return on Invested Capital (CROIC)
-229.94% -165.16% -139.24% -110.42% -97.08% -86.84% -69.83% -74.95% -75.52% -78.56% -68.08%
Operating Return on Assets (OROA)
-29.44% -21.61% -24.56% -22.30% -22.56% -23.04% -24.77% -16.60% -12.98% -8.13% -12.37%
Return on Assets (ROA)
-30.32% -21.38% -24.35% -20.93% -19.99% -20.24% -22.25% -14.73% -11.18% -6.66% -10.83%
Return on Common Equity (ROCE)
-32.85% -25.44% -29.04% -23.67% -23.54% -25.04% -26.62% -16.65% -13.01% -8.19% -12.54%
Return on Equity Simple (ROE_SIMPLE)
-62.78% 0.00% -58.51% -26.87% -25.07% 0.00% -26.05% -24.80% -22.67% 0.00% -15.87%
Net Operating Profit after Tax (NOPAT)
-9.50 -7.91 -7.91 -8.37 -7.82 -8.75 -8.43 -7.05 -5.34 -3.85 -5.24
NOPAT Margin
-35.93% -24.74% -24.17% -25.14% -22.99% -22.53% -22.26% -17.65% -13.25% -7.85% -11.07%
Net Nonoperating Expense Percent (NNEP)
-4.86% -3.91% -4.62% -2.74% -2.26% -2.38% -2.94% -1.53% -1.02% -0.54% -1.14%
Return On Investment Capital (ROIC_SIMPLE)
- -5.80% - - - -4.23% - - - -1.89% -2.58%
Cost of Revenue to Revenue
15.77% 15.93% 18.11% 18.97% 20.70% 26.21% 21.13% 21.00% 20.91% 20.87% 20.29%
SG&A Expenses to Revenue
26.76% 22.12% 22.85% 23.43% 22.67% 20.80% 21.59% 20.85% 20.07% 18.68% 21.06%
R&D to Revenue
11.69% 10.89% 10.06% 10.98% 11.52% 10.71% 11.47% 10.89% 9.90% 7.90% 9.59%
Operating Expenses to Revenue
135.56% 119.42% 116.41% 116.95% 112.14% 105.98% 110.67% 104.22% 98.01% 90.35% 95.53%
Earnings before Interest and Taxes (EBIT)
-14 -11 -11 -12 -11 -13 -12 -10 -7.63 -5.49 -7.47
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-13 -11 -11 -11 -11 -12 -13 -10 -7.74 -5.44 -7.08
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
5.82 4.77 7.32 5.35 4.92 5.02 4.01 3.23 3.53 3.52 3.56
Price to Tangible Book Value (P/TBV)
5.82 4.77 7.32 5.35 4.92 5.02 4.01 3.23 3.53 3.52 3.56
Price to Revenue (P/Rev)
6.01 4.41 5.90 7.63 6.47 6.12 4.60 3.54 3.71 3.52 3.37
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
14.39 10.50 13.79 17.72 16.21 17.63 12.05 8.33 9.12 8.91 8.27
Enterprise Value to Revenue (EV/Rev)
5.35 3.85 5.49 6.58 5.49 5.20 3.77 2.78 2.99 2.84 2.76
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.37 0.39 0.41 0.22 0.22 0.22 0.23 0.22 0.23 0.22 0.22
Long-Term Debt to Equity
0.36 0.39 0.41 0.22 0.22 0.22 0.23 0.22 0.23 0.22 0.22
Financial Leverage
-0.78 -0.72 -0.64 -0.72 -0.70 -0.70 -0.65 -0.72 -0.72 -0.72 -0.69
Leverage Ratio
1.43 1.50 1.51 1.39 1.41 1.45 1.44 1.34 1.35 1.37 1.36
Compound Leverage Factor
1.47 1.46 1.49 1.30 1.25 1.29 1.29 1.19 1.17 1.10 1.19
Debt to Total Capital
27.14% 27.90% 29.05% 17.71% 17.91% 18.16% 18.39% 18.36% 18.45% 17.87% 17.74%
Short-Term Debt to Total Capital
1.03% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
26.11% 27.90% 29.05% 17.71% 17.91% 18.16% 18.39% 18.36% 18.45% 17.87% 17.74%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
72.86% 72.10% 70.95% 82.29% 82.09% 81.84% 81.61% 81.64% 81.55% 82.13% 82.26%
Debt to EBITDA
-0.66 -0.68 -0.76 -0.85 -0.88 -0.83 -0.79 -0.80 -0.86 -1.00 -1.17
Net Debt to EBITDA
1.13 1.06 0.94 2.92 2.98 2.84 2.56 2.47 2.63 3.15 3.52
Long-Term Debt to EBITDA
-0.63 -0.68 -0.76 -0.85 -0.88 -0.83 -0.79 -0.80 -0.86 -1.00 -1.17
Debt to NOPAT
-0.88 -0.91 -1.02 -1.13 -1.18 -1.14 -1.12 -1.16 -1.26 -1.47 -1.68
Net Debt to NOPAT
1.51 1.42 1.26 3.90 4.03 3.91 3.61 3.57 3.84 4.61 5.04
Long-Term Debt to NOPAT
-0.85 -0.91 -1.02 -1.13 -1.18 -1.14 -1.12 -1.16 -1.26 -1.47 -1.68
Altman Z-Score
4.68 2.90 5.47 9.18 7.99 7.32 5.71 4.27 4.53 4.52 4.88
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
7.50 6.50 7.72 11.68 10.89 9.01 9.76 9.17 8.25 7.66 8.53
Quick Ratio
6.49 5.57 6.53 10.43 9.64 8.01 8.63 7.99 7.12 6.54 7.14
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-29 -20 -24 -20 -16 -11 -6.99 -11 -12 -16 -19
Operating Cash Flow to CapEx
-182.73% -408.13% -416.94% -132.28% -146.71% -210.16% -363.64% -203.47% 9.95% 51.99% -237.02%
Free Cash Flow to Firm to Interest Expense
-38.21 -23.13 -28.33 -22.96 -17.54 -11.95 -7.93 -12.65 -13.68 -20.34 -28.91
Operating Cash Flow to Interest Expense
-8.65 -7.69 -12.83 -4.22 -2.35 -2.58 -8.59 -7.20 0.34 1.48 -7.42
Operating Cash Flow Less CapEx to Interest Expense
-13.38 -9.57 -15.91 -7.42 -3.94 -3.81 -10.96 -10.74 -3.09 -1.37 -10.55
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.57 0.61 0.72 0.62 0.68 0.72 0.77 0.66 0.69 0.73 0.78
Accounts Receivable Turnover
6.86 6.09 6.61 7.00 7.24 6.52 6.44 6.67 7.00 6.77 7.24
Inventory Turnover
1.03 1.09 1.15 1.16 1.24 1.57 1.62 1.54 1.46 1.48 1.43
Fixed Asset Turnover
8.92 8.67 8.67 8.19 8.53 8.80 8.48 8.22 8.43 9.19 9.19
Accounts Payable Turnover
3.20 3.31 3.61 3.81 5.40 5.42 4.86 5.04 5.97 6.33 4.77
Days Sales Outstanding (DSO)
53.22 59.89 55.19 52.14 50.39 56.01 56.64 54.76 52.18 53.94 50.44
Days Inventory Outstanding (DIO)
353.47 334.44 318.05 314.35 293.44 232.45 224.71 237.66 249.41 246.35 256.09
Days Payable Outstanding (DPO)
114.16 110.13 101.10 95.91 67.64 67.31 75.17 72.40 61.18 57.66 76.52
Cash Conversion Cycle (CCC)
292.53 284.20 272.14 270.58 276.19 221.16 206.18 220.02 240.41 242.64 230.02
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
37 39 46 46 45 41 45 50 51 53 59
Invested Capital Turnover
3.64 3.24 3.03 3.06 3.23 3.47 3.15 3.13 3.26 3.55 3.40
Increase / (Decrease) in Invested Capital
19 12 16 11 7.69 1.88 -1.44 4.07 6.75 12 14
Enterprise Value (EV)
533 410 641 818 725 722 542 418 469 474 487
Market Capitalization
599 469 688 949 854 850 663 533 583 588 596
Book Value per Share
$3.00 $2.85 $2.69 $5.04 $4.32 $4.18 $4.04 $4.00 $3.96 $3.98 $3.94
Tangible Book Value per Share
$3.00 $2.85 $2.69 $5.04 $4.32 $4.18 $4.04 $4.00 $3.96 $3.98 $3.94
Total Capital
141 136 132 216 211 207 203 202 202 203 203
Total Debt
38 38 38 38 38 38 37 37 37 36 36
Total Long-Term Debt
37 38 38 38 38 38 37 37 37 36 36
Net Debt
-66 -59 -48 -131 -129 -128 -121 -114 -113 -114 -108
Capital Expenditures (CapEx)
3.57 1.66 2.58 2.71 1.41 1.09 2.08 3.11 3.04 2.27 2.07
Debt-free, Cash-free Net Working Capital (DFCFNWC)
18 19 26 25 25 22 25 29 28 31 36
Debt-free Net Working Capital (DFNWC)
122 116 112 194 192 188 183 180 179 181 180
Net Working Capital (NWC)
121 116 112 194 192 188 183 180 179 181 180
Net Nonoperating Expense (NNE)
4.66 3.27 3.22 2.83 2.20 2.23 2.47 1.88 1.23 0.65 1.31
Net Nonoperating Obligations (NNO)
-66 -59 -48 -131 -129 -128 -121 -114 -113 -114 -108
Total Depreciation and Amortization (D&A)
1.11 0.65 0.55 0.64 0.41 0.02 -0.43 -0.42 -0.11 0.05 0.39
Debt-free, Cash-free Net Working Capital to Revenue
18.05% 17.99% 22.12% 20.02% 18.86% 15.78% 17.32% 19.07% 17.96% 18.31% 20.29%
Debt-free Net Working Capital to Revenue
122.46% 109.42% 95.80% 156.22% 145.21% 135.32% 126.88% 119.62% 114.00% 108.06% 102.07%
Net Working Capital to Revenue
121.00% 109.42% 95.80% 156.22% 145.21% 135.32% 126.88% 119.62% 114.00% 108.06% 102.07%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.41) ($0.32) ($0.32) ($0.30) ($0.25) ($0.26) ($0.27) ($0.22) ($0.16) ($0.10) ($0.15)
Adjusted Weighted Average Basic Shares Outstanding
34.36M 34.20M 34.92M 37.86M 40.27M 38.43M 40.93M 41.32M 41.72M 41.47M 42.34M
Adjusted Diluted Earnings per Share
($0.41) ($0.32) ($0.32) ($0.30) ($0.25) ($0.26) ($0.27) ($0.22) ($0.16) ($0.10) ($0.15)
Adjusted Weighted Average Diluted Shares Outstanding
34.36M 34.20M 34.92M 37.86M 40.27M 38.43M 40.93M 41.32M 41.72M 41.47M 42.34M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
34.50M 34.99M 35.18M 40.20M 40.50M 41.06M 41.20M 41.69M 41.94M 42.45M 42.61M
Normalized Net Operating Profit after Tax (NOPAT)
-9.50 -7.91 -7.91 -8.37 -7.82 -8.75 -8.43 -7.05 -5.34 -3.85 -5.24
Normalized NOPAT Margin
-35.93% -24.74% -24.17% -25.14% -22.99% -22.53% -22.26% -17.65% -13.25% -7.85% -11.07%
Pre Tax Income Margin
-53.56% -34.56% -34.01% -33.65% -29.46% -28.63% -28.80% -22.36% -16.31% -9.01% -13.83%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-18.21 -12.82 -13.39 -14.04 -12.80 -14.05 -13.78 -11.45 -8.63 -6.91 -11.29
NOPAT to Interest Expense
-12.58 -8.97 -9.43 -9.85 -8.84 -9.84 -9.57 -8.02 -6.04 -4.84 -7.91
EBIT Less CapEx to Interest Expense
-22.94 -14.70 -16.47 -17.24 -14.39 -15.28 -16.14 -14.99 -12.07 -9.76 -14.42
NOPAT Less CapEx to Interest Expense
-17.31 -10.86 -12.51 -13.04 -10.44 -11.06 -11.93 -11.55 -9.48 -7.69 -11.04
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Key Financial Trends

  • Operating revenue rose 24.9% year-over-year to $47.3 M in Q1 2025, driven by healthy demand growth.
  • Gross margin remained robust at 79.7%, consistent with prior quarters.
  • Cash & equivalents totaled $41.2 M at quarter end, supporting a strong quick ratio of 7.14.
  • Altman Z-Score of 4.88 suggests financial stability well above distress levels.
  • Cash conversion cycle improved to 230 days, down from 242 days a year earlier.
  • Debt-to-equity of 0.22 remains modest, indicating manageable leverage.
  • Capital expenditures of $2.07 M reflect ongoing investment in plant and equipment.
  • Net loss widened to $6.54 M (-$0.15 per share), compared with ‑$4.50 M (-$0.10 per share) in Q4 2024.
  • Operating income stayed negative at ‑$7.48 M, unchanged pace of unprofitability.
  • Free cash flow to firm was ‑$19.1 M, highlighting continued cash burn from operations and investments.
07/18/25 02:50 AMAI Generated. May Contain Errors.

Frequently Asked Questions About SiBone's Financials

When does SiBone's financial year end?

According to the most recent income statement we have on file, SiBone's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has SiBone's net income changed over the last 7 years?

SiBone's net income appears to be on an upward trend, with a most recent value of -$30.91 million in 2024, rising from -$23.04 million in 2017. The previous period was -$43.34 million in 2023. Check out SiBone's forecast to explore projected trends and price targets.

What is SiBone's operating income?
SiBone's total operating income in 2024 was -$35.25 million, based on the following breakdown:
  • Total Gross Profit: $132.12 million
  • Total Operating Expenses: $167.37 million
How has SiBone's revenue changed over the last 7 years?

Over the last 7 years, SiBone's total revenue changed from $47.98 million in 2017 to $167.18 million in 2024, a change of 248.4%.

How much debt does SiBone have?

SiBone's total liabilities were at $63.47 million at the end of 2024, a 4.0% increase from 2023, and a 36.0% increase since 2017.

How much cash does SiBone have?

In the past 7 years, SiBone's cash and equivalents has ranged from $10.44 million in 2019 to $63.42 million in 2021, and is currently $34.95 million as of their latest financial filing in 2024.

How has SiBone's book value per share changed over the last 7 years?

Over the last 7 years, SiBone's book value per share changed from -37.32 in 2017 to 3.98 in 2024, a change of -110.7%.



This page (NASDAQ:SIBN) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners